Illumina, Inc. is an American biotech company with its headquarters in San Diego, California. It is a health tech company that develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.

On Tuesday after the close, Illumina will report its earnings. Historically the stock tends to gain over this period of time with a 73% win percentage between February 3 and February 15. So, does this mean that Illumina will repeat its seasonal pattern again this year? Or will earnings disappoint and send the stock lower?

Major Trade Risks: The major trade risk here is that the seasonal pattern does not repeat itself again this year.

HYCM clients can access the Seasonax product in order to analyse over 25,000 currency pairs, indices, commodities, as well as individual stocks. Please contact your account manager for a free trial. Certain products & services mentioned herein may or may not be available to all clients depending on which HYCM Capital Markets Group entity their trading account(s) adheres to.